Microheterogeneity of serum glycoproteins and their liver precursors in patients with carbohydrate-deficient glycoprotein syndrome type I: Apparent deficiencies in clusterin and serum amylaid P

Journal of Laboratory and Clinical Medicine

Volumn 129, Issue 4, 1997, Pages 412-421

  Henry, Hugues ^b   Tissot, Jean Daniel ^b   Messerli, Barbara ^b   Markert, Michèle ^b   Muntau, Ania ^b   Skladal, Daniela ^b   Sperl, Wolfgang ^b   Jaeken, Jaak ^b   Weidinger, Sebastian ^b   Heyne, Klaus ^b   Bachmann, Claude ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 12644271204     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90074-3     Document Type: Article

References (34)

1. Jaeken J, Carchon H, Stibler H. The carbohydrate-deficient glycoprotein syndromes: pre-Golgi and Golgi disorders? Glycobiology 1993;3:423-8.
2. Jaeken J, Schachter H, Carchon H, de Cock P, Coddeville B, Spik G. Carbohydrate-deficient glycoprotein syndrome type II: a deficiency in Golgi localised N-acetyl-glucosaminyltransferase II. Arch Dis Child 1994;71:123-7.
3. Hagberg B, Blennow G, Kristiansson B, Stibler H. Carbohydrate-deficient glycoprotein syndromes: peculiar group of new disorders. Pediatr Neurol 1993;9:255-62.
4. Stibler H, Jaeken J. Carbohydrate deficient serum transferrin in a new systemic hereditary syndrome. Arch Dis Child 1990; 65:107-11.
5. Stibler H, Jaeken J, Kristiansson B. Biochemical characteristics and diagnosis of the carbohydrate-deficient glycoprotein syndrome. Acta Pediatr Scand 1991;3775(suppl):21-31.
6. Ohno K, Yuasa I, Akaboshi S, Itoh M, Yoshida K, Ehara H, et al. The carbohydrate-deficient glycoprotein syndrome in three Japanese children. Brain Dev 1992;14:30-5.
7. Heyne K, Weidinger S. Diagnostick und nosologie der glykanose CDG (carbohydrate-deficient glycoprotein syndrome). Monatsschr Kinderheilkd 1992;140:822-7.
8. Harrison H, Miller K. Multiple serum protein abnormalities in carbohydrate-deficient glycoprotein syndrome: pathognomonic finding of two-dimensional electrophoresis. Clin Chem 1992;38:1390-2.
9. Heyne K, Weidinger S. Drei neue biochemische marker bei glycanose CDG (carbohydrate-deficient glycoprotein syndrome). Monatsschr Kinderheilkd 1994;142:199-204.
10. Yuasa I, Ohno K, Hashimoto K, Iijima K, Yamashita K, Takeshita K. Carbohydrate-deficient glycoprotein syndrome: electrophoretic study of multiple serum glycoproteins. Brain Dev 1995;17:13-9.
11. Stibler H, Stephani U, Kutsch U. Carbohydrate-deficient glycorotein syndrome - a fourth subtype. Neuropediatrics 1995;26:1-3.
12. Van Schaftingen E, Jaeken J. Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I. FEBS Lett 1995;377:318-20.
13. Krasnewich D, Holt GD, Brantly M, Skovby F, Redwine J, Gahl WA. Abnormal synthesis of dolichol-linked oligosaccharides in carbohydrate-deficient glycoprotein syndrome. Glycobiology 1995;5:503-10.
14. Martisson T, Bjursell C, Stibler H, Kristiansson B, Skovby F, Jaeken J, et al. Linkage of a locus for carbohydrate-deficient glycoprotein syndrome type I (CDG1) to chromosome 16p, and linkage disequilibrium to microsatellite marker D16S406. Hum Mol Gen 1995;3:2037-42.
15. Skladal D, Sperl W, Henry H, Bachmann C. Congenital cataract and familiar brachydactyly in carbohydrate-deficient glycoprotein syndrome. J Inherit Metab Dis 1996;19: 251-2.
16. Görg A, Postel W, Domscheit A, Gunther S. Two-dimensional electrophoresis with immobilized pH gradients of proteins from barley (Hordeum vulgare): method, reproducibility and genetic aspects. Electrophoresis 1988;9:681-92.
17. Hochstrasser DF, Patchornik A, Merril CR. Development of polyacrylamide gels that improve the separation of proteins and their detection by silver staining. Anal Biochem 1988; 173:412-23.
18. Hughes GJ, Frutiger S, Paquet N, Ravier F, Pasquali C, Sanchez J-C, et al. Plasma protein map: an update by microsequencing. Electrophoresis 1992;13:707-14.
19. Bjellqvist B, Basse B, Olsen E, Celis JE. Reference points for comparisons of two-dimensional maps of proteins from different human cell types defined in a pH scale where isoelectric points correlate with polypeptide compositions. Electrophoresis 1994;15:529-39.
20. Laurière M. A semidry electroblotting system efficiently transfers both high- and low-molecular-weight proteins separated by SDS-PAGE. Anal Biochem 1993;212:206-11.
21. Golaz O, Hughes GJ, Frutiger S, Paquet N, Bairoch A, Pascali C, et al. Plasma and red cell protein maps: update 1993. Electrophoresis 1993;13:707-14.
22. Yamashita K, Ohkura T, Ideo H, Ohno K, Kanai M. Electrospray ionization-mass spectrometric analysis of serum transferrin isoforms in patients with carbohydrate-deficient glycoprotein syndrome. J Biochem 1993;114:766-9.
23. Wada Y, Nishikawa A, Okamoto N, Inui K, Tsukamoto H, Okada S, et al. Structure of serum transferrin in carbohydrate-deficient glycoprotein syndrome. Biochem Biophys Res Commun 1992;189:832-6.
24. Gianazza E. Isoelectric focusing as a tool for the investigation of post-translational processing and chemical modifications of proteins. J Chromatogr 1995;705:67-87.
25. Yamashita K, Ideo H, Ohkura T, Fukushima K, Yuasa I, Ohno K, et al. Sugar chains of serum transferrin from patients with carbohydrate-deficient glycoprotein syndrome. Evidence of asparagine-N-linked oligosaccharide transfer deficiency. J Biol Chem 1992;268:5783-9.
26. Hochstrasser AC, James RW, Martin BM, Harrington M, Hochstrasser D, Pometta D, et al. HDL particle associated proteins in plasma and cerobrospinal fluid: identification and partial sequencing. Appl Theor Electrophor 1988;1: 73-6.
27. Jenne DE, Lowin B, Peitsch MC, Bottcher A, Schmitz G, Tscopp J. Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apolipoprotein A-1 in human plasma. J Biol Chem 1991;266:11030-6.
28. De Silva HV, Harmony JAK, Stuart WD, Gil CM, Robbins J. Apolipoprotein J: structure and tissue distribution. Biochemistry 1990;29:5380-9.
29. Rosenberg ME, Silkensen J. Clusterin: physiologic and pathophysiologic considerations. Int J Biochem Cell Biol 1995;27:633-45.
30. García de Frutos P, Dahlbäck B. Interaction between serum amyloid P component and C4b-binding protein associated with inhibition of factor I-mediated C4b degradation. J Immunol 1994;152:2430-7.
31. Breathnach SL, Kofler H, Sepp N, Ashworth J, Woodrow D, Pepys MB, et al. Serum amyloid P component binds to cell nuclei in vitro and to in vivo deposits of extracellular chromatin in systemic lupus rythematosus. J Exp Med 1989;170: 1433-8.
32. Appel D, Pilarsky C, Graichen R, Koch-Brandt C. Sorting of gp80 (GPIII, clusterin), a marker protein for constitutive apical secretion in Madin-Darby canine kidney (MDCK) cells, into the regulated pathway in the pheochromocytoma cell line PC12. Eur J Cell Biol 1996;70:142-9.
33. Lippincott-Schwartz J, Bonifacino JS, Yuan LC, Klausner RD. Degradation from the endoplasmic reticulum: disposing of newly synthesized proteins. Cell 1988;54:209-20.
34. Marquardt T, Ullrich K, Zimmer P, Hasilik A, Deufel T, Harms E. Carbohydrate-deficient glycoprotein syndrome (CDGS)-glycosylation, folding and intracellular transport of newly synthesized glycoproteins. Eur J Cell Biol 1995;66:268-73.